3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results. (September 2015) - Juhasz, E.; Ramalingam, S.; Blais, N.; Mazieres, J.; Reck, M.; Jones, M.; Urban, L.; Orlov, S.; Barlesi, F.; Kio, E.; Keilholz, U.; Qian, J.; et al.